Key result
A combination of rivaroxaban and clopidogrel resulted in partial regression of a recurrent sessile thrombus on the posterior wall of a gigantic left atrium after mitral valve surgery.
Why the study?
Does a combination of rivaroxaban and clopidogrel improve thrombus regression in a patient with a gigantic left atrium and recurrent thrombus despite effective vitamin K antagonist therapy?
Case Report (n=1)
No
Does a combination of rivaroxaban and clopidogrel improve thrombus regression in a patient with a gigantic left atrium and recurrent thrombus despite effective vitamin K antagonist therapy?
Off-label use of rivaroxaban combined with clopidogrel successfully reduced a recurrent left atrial thrombus in a patient with a gigantic left atrium and biological mitral valve after VKA failure.
Answers are grounded in this paper and cite their sources.
May offer an alternative for recurrent LA thrombus after VKA failure in giant LA; hypothesis-generating and requires prospective validation.
BACKGROUND: Gigantic left atrium is defined in the current literature as an excessive dilatation of the left atrium above 65mm. Chronic mitral valve disease is associated with the development of thrombus in the left atrium in up to 19% of all cases of mitral insufficiency and appropriate treatment must be initiated to prevent thromboembolic events. In order to diagnose thrombi in the left atrium or left atrial appendage, various imaging methods may be used, including cardiac magnetic resonance. CASE PRESENTATION: The case report describes a 73-year-old male who developed recurrent sessile thrombus on the posterior wall of the gigantic left atrium. A large thrombus was first detected following mitral valve surgery despite effective vitamin K antagonist anticoagulation therapy. Echocardiography and cardiac magnetic resonance were used within the diagnostic procedure and to monitor the treatment outcomes. Cardiac magnetic resonance was shown to be beneficial as it provided a more precise description of the intra-atrial masses located on the posterior left atrial wall, and in such situations, is of greater benefit than standard echocardiography. This led to the surgical removal of the intra-atrial mass; nevertheless, it was quickly followed by the recurrence of the thrombus. The anticoagulant therapy was adjusted and fortified by the introduction of acetylsalicylic acid and sequentially clopidogrel, but this also did not resolve the thrombus formation. Finally, employing a combination of rivaroxaban and clopidogrel resulted in partial thrombus regression. Therefore, various pathophysiological aspects of thrombus formation and used anticoagulation strategies are discussed. CONCLUSIONS: We describe a unique case of a recurrent thrombus located on the posterior wall of the gigantic left atrium. Cardiac magnetic resonance was shown to be beneficial in providing a more precise description of the intra-atrial masses located on the posterior left atrial wall as compared to standard echocardiographic examination. Development of a thrombus after mitral valve surgery despite effective anticoagulant therapy and its final resolution by introducing a combination of rivaroxaban and clopidogrel highlights the complex etiopathogenesis of thrombus formation. This supports the potential use of this combination in tailoring an individual personalized therapy for patients with recurrent atrial thrombi.
No takes yet. Share an insight, caveat, or question.
Masárová et al. (2020) conducted a case report in Recurrent left atrial thrombus with gigantic left atrium and atrial fibrillation (n=1). Rivaroxaban and clopidogrel vs. Vitamin K antagonists (previous therapy) was evaluated on Thrombus size reduction. A combination of rivaroxaban and clopidogrel resulted in partial regression of a recurrent sessile thrombus on the posterior wall of a gigantic left atrium after mitral valve surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: